Please enter a valid month/year e.g. 01/2015

Pick a date between March 2000 and July 2018

Showing 1 to 10 of 14
Title Consultation Type Consultation end date
Lenvatinib and sorafenib for treating differentiated thyroid cancer after radioactive iodine [ID1059] Appraisal consultation: 2 Technology appraisal guidance Type:23 April 2018 20180423
Dupilumab for treating moderate to severe atopic dermatitis after topical treatments [ID1048] Appraisal consultation Technology appraisal guidance Type:24 April 2018 20180424
Pancreatitis: diagnosis and management Draft guidance consultation NICE guideline Type:25 April 2018 20180425
Cardiovascular disease: identifying and supporting people most at risk of dying early Surveillance consultation NICE guideline Type:25 April 2018 20180425
Cardiovascular disease prevention Surveillance consultation NICE guideline Type:25 April 2018 20180425
Ocrelizumab for treating relapsing multiple sclerosis [ID937] Appraisal consultation Technology appraisal guidance Type:25 April 2018 20180425
Alectinib for untreated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer [ID925] Appraisal consultation: 1 Technology appraisal guidance Type:26 April 2018 20180426
Chronic heart failure in adults: diagnosis and management Draft guidance consultation NICE guideline Type:26 April 2018 20180426
Tumour profiling tests to guide adjuvant chemotherapy decisions in people with breast cancer (update of DG10) Diagnostics consultation: 2 Diagnostics guidance Type:11 May 2018 20180511
Emergency and acute medical care in over 16s Quality standard consultation Quality standard Type:14 May 2018 20180514